The Pension Lab offers an interative platform for employees and individuals, helping them reconnect and engage with their pensions. Its mission is to provide the customers with better knowledge of pensions and promote long-term financial decision making. The company has reached the finals of 'Pitchfest' competition held at the NEC as a component of “Venturefest”, and it is also a finalist in the “Innovation in Business” category. Some of the best Fintech solutions providers and pension services such as Yodlee and Origo are in partnership with the Pension Lab. With the proceeds, the company will develop its working capital, infrastructure development, and customer acquisition.
days to go:
Expired
investment:
£38,024
Thyngs is a touch-free instant payment platform for businesses and charities. It has around 20 active re-seller partners for new sectors and markets. The company is working with PricewaterhouseCoopers (PwC) as part of its raise programme and actively engaging with several Series A Venture Capitalist (VC) funds intending to raise £4-5 million in late 2021 to scale its business. Thyngs aggregates various payment partners including PayPal, Worldpay, Apple Pay and Google Pay. The company was the cashless donation platform for 210,000 fundraising events for Macmillan's 'World's Biggest Coffee Morning', which raised £27 million in 2019. Many reputed organisations such as Warner Bros, Royal British Legion, Wasabi, National Geographic, and ANZ Bank are working with Thyngs. The company will use the investment to enhance its marketing campaign, bolster its sales team, work on data security and integrations on its platform, and expand the account management team to boost its business.
days to go:
Expired
investment:
£329,591
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
Ascot Brewing are passionate brewing award-winning real ales and hop-forward craft beers. They are on a mission to deliver value for its shareholders and customers while providing opportunities for its employees. They have opened a 2,500sq ft,20 tap - taproom and launched its hop-forward craft beer brand. Till now there are 785 investors backing Ascot Brewing Company and they have recently moved to new 8,500 sq. Ft building & installed new brewing kit. The company have successfully launched our hop-forward craft beer brand (Disruption is Brewing®). Ascot Brewing is seeking investment to expand the sales team, build out one of the best taprooms in the UK, growing export trade, add a small canning line, and address export inquiries.
days to go:
Expired
investment:
£150,000
Doodle Drinks (DD) aims to make all-natural soft drinks that kids can enjoy. The company cites research data arguing that children aged 18 months to 18 years are drinking 26% fewer sugary drinks and consumption for 10-year olds has fallen 35%. It wants to capture this sentiment and deliver a soft drink that's a healthy choice for both parents and their kids. DD has secured distribution with the noted distributor, Bravura Foods. It has also signed a partnership with the largest independent bottler of beverages in Europe and North America, Refresco, who have over 60 manufacturing sites globally to fulfil its objective. DD will use the investment to grow its business, execute its marketing strategy and increase its product range.
days to go:
Expired
investment:
£877,830
TheVeganKind is a plant-based supermarket subscription box service that sells different vegan and plant-based products. The company has generated a revenue of £2.5m during Nov 2018-Nov 2019. TheVeganKind had shipped more than 130,000 orders alone in 2019. There are more than 4,500 different vegan and plant-based products in stock. It has been recently voted the UK's Top Online Retailer for Vegan Shopping. TheVeganKind has more than 500,000 social followers across Facebook, Twitter, and Instagram. With the proceeds, the company will allocate 60% of the funds towards marketing and branding; 20% will go towards warehouse expansion, and in increasing its inventory; 20% will go towards operating expenditure and team expansion.
days to go:
Expired
investment:
£669,188
Alyve provides personalised subscription nutrition powered by Artificial Intelligence (AI). It argues that 8.2 million UK vitamin users are looking for personalised nutrition in one capsule. Alyve asserts that its product can fulfil this demand. Users complete a 3-minute questionnaire where their responses are recorded by Alyve's intelligent algorithms. These then, based on the responses, help the user select one of Alyve's nutritional pills best matched to their goals and needs. Alyve then delivers the pills to the user's doorstep every 30 days. The company has recorded 4000+ questionnaires and completed 800+ orders in 25 countries since Q4 of 2020. It aims to become a contender in the $21 billion supplement market. The company will use the investment received to increase marketing efforts, transform Alyve into a household brand, introduce new product lines, increase staff, improve technology, and transform both digital and physical User Experiences (UX).
days to go:
Expired
investment:
£227,782
Glint is a proprietary multi-currency platform that allows users to buy, save, spend and send real gold and other currencies, digitally with its application. The company asserts that its scalable technology enables its clients to use their currencies such as GBP, USD, EUR and Gold, with Glint's UK, EU and US-issued Mastercards in 210 countries worldwide. Glint also points out that its Peer-to-Peer (P2P) Service, Glint It!, allows clients to send and receive gold and currency between Glint accounts in over 160 countries. The company has raised £20 million in equity funding to date, reached 79,000 registered clients, and overseen over £158 million worth of transactions on its platform. Glint will use the investment to maximise revenue, organically grow its business, increase its registered customer base to 250,000 in 2021, and hire key personnel across various portfolios.
days to go:
Expired
investment:
£3,072,539
Nelson's Distillery & School (NDAS) makes and sells craft gin from its 290-litre state-of-the-art establishment. It also educates interested folks from its 28 seat Gin school in the art of making quality craft gin. Former Chef and founder, Neil Harrison, set out to create the best craft Gin and to educate others in the process. The company has produced and sold over 100,000 bottles since its founding in 2019. It aspires to become a contender in the global gin market valued at $15 billion. NDAS asserts that it is one of a few craft gin companies to win the coveted 3-star Great British Taste award, plus 6 other awards over 2 years. The company has also signed four contracts with the Hilton & Clayton hotels, three in the UK and one in Asia. NDAS will use the investment to expand its business and establish Nelson’s Gin school in all major cities.
days to go:
Expired
investment:
£317,868
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.
days to go:
Expired
investment:
£1,646,249
